⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for tumor metabolism

Every month we try and update this database with for tumor metabolism cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Calorie Restriction With or Without Metformin in Triple Negative Breast CancerNCT04248998
Triple-negative...
Fasting-mimicki...
Metformin
Preoperative ch...
18 Years - 75 YearsFondazione IRCCS Istituto Nazionale dei Tumori, Milano
Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)NCT02771626
Clear Cell Rena...
Melanoma
Non-small Cell ...
CB-839
Nivolumab
18 Years - Calithera Biosciences, Inc
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid TumorsNCT03875313
Solid Tumor
Clear Cell Rena...
TNBC - Triple-N...
Colorectal Canc...
CRC
RCC
ccRCC
CB-839
Talazoparib
18 Years - Calithera Biosciences, Inc
Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)NCT02771626
Clear Cell Rena...
Melanoma
Non-small Cell ...
CB-839
Nivolumab
18 Years - Calithera Biosciences, Inc
Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)NCT03057600
Triple Negative...
TNBC - Triple-N...
Paclitaxel
CB-839
18 Years - Calithera Biosciences, Inc
Effects of Topical Diclofenac on Tumor MetabolismNCT01935531
Actinic Keratos...
3% diclofenac i...
18 Years - University Hospital Regensburg
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid TumorsNCT03875313
Solid Tumor
Clear Cell Rena...
TNBC - Triple-N...
Colorectal Canc...
CRC
RCC
ccRCC
CB-839
Talazoparib
18 Years - Calithera Biosciences, Inc
Calorie Restriction With or Without Metformin in Triple Negative Breast CancerNCT04248998
Triple-negative...
Fasting-mimicki...
Metformin
Preoperative ch...
18 Years - 75 YearsFondazione IRCCS Istituto Nazionale dei Tumori, Milano
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)NCT03163667
Clear Cell Rena...
Placebo
CB-839
everolimus
18 Years - Calithera Biosciences, Inc
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)NCT03163667
Clear Cell Rena...
Placebo
CB-839
everolimus
18 Years - Calithera Biosciences, Inc
Study of the Glutaminase Inhibitor CB-839 in Solid TumorsNCT02071862
Solid Tumors
Triple-Negative...
Non Small Cell ...
Renal Cell Carc...
Mesothelioma
Fumarate Hydrat...
Succinate Dehyd...
Succinate Dehyd...
Tumors Harborin...
Tumors Harborin...
CB-839
Pac-CB
CBE
CB-Erl
CBD
CB-Cabo
18 Years - Calithera Biosciences, Inc
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: